Sushant Wagley, MD
Retina Specialist · West Des Moines, IANPI 1225481351
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,325 of the $6,345 with a category attached, or 83.9%. Genentech USA, Inc. accounts for 77.3% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $3,802 and has fallen 93.6% since, to $243 in 2025.
Across 13 payments — averaging $488.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$5K
- Eyepoint US, Inc.$1K
- Bausch & Lomb Americas Inc.$146
- Alimera Sciences, Inc.$122
- Tarsus Pharmaceuticals, Inc.$121
- AbbVie$39
What the payments were for
- Consulting fees$5,32584%
- Travel & lodging$3235%
- Food & beverage$69711%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 4 | $4,901 |
| Eyepoint US, Inc. | 2 | $1,015 |
| Bausch & Lomb Americas Inc. | 2 | $146 |
| Alimera Sciences, Inc. | 2 | $122 |
| Tarsus Pharmaceuticals, Inc. | 1 | $121 |
| AbbVie | 2 | $39 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few retina specialist providers in Iowato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 155 | $4,511 |
| Tobramycin | 108 | $533 |
| Ketorolac Tromethamine | 15 | $359 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 28 | $248 |
| ErythromycinErythromycin Base | 21 | $197 |
| Latanoprost | 13 | $143 |
| Timolol Maleate | 25 | $130 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in West Des Moines
- Austin StrohbehnWest Des Moines$5K
- James SingerWest Des Moines$3K
- Riley BylundWest Des Moines$2K
- Christopher HaupertWest Des Moines$1K
- David MassopDes Moines$3K
- Mohammad SabbaghSioux City$2K
- Justin GrassmeyerIowa City$877
- Ravi PanditSioux City$855
- Beau FennerIowa City$45
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.